Takeda Ireland introduces digital pharma operations
Successful transformation to paperless factory brings huge benefits in quality, regulatory compliance, operations and data availability.
Takeda Ireland has implemented Werum’s PAS-X Manufacturing Execution System (MES) in a phased approach at its Grange Castle, Ireland, production site.
“With the help of Werum’s PAS-X MES we were able to successfully transform our Grange Castle site into a paperless factory,” says Paul Keogh, Plant Director at Takeda Ireland Limited Grange Castle. “The new digital operations provide huge quality, regulatory, operational, and data availability benefits. Example benefits include work standardization, human error avoidance, data entry reduction, batch review by exception, manufacturing decision support, material management, data visualization, etc. Moreover, the MES-based Level 2-4 integration architecture provides a solid platform for digital innovation and operational expansion.”
Werum’s PAS-X MES automatically pulls manufacturing data from the shop floor by integrating Takeda’s Process Control System via OSIsoft PI Historian. Thus, approximately 94% of all parameters in each batch record are automatically entered to the batch record. MES is configured to download recipes to the process control layer and to synchronize Electronic Batch Recording (EBR) with process controls in real-time to ensure batch data entry is contemporaneous and original as production progresses. In addition to the basic data integrity benefits, PAS-X EBR enforces additional operator confirmations and electronic signatures where required based on GxP and safety risks. Through EBR the manufacturing process is highly standardized, and batch review by exception is supported.
In addition to the shop floor integration, new PAS-X SAP interfaces were developed during the Takeda Ireland project as part of a global SAP template rollout across Takeda. These interfaces enable a seamless exchange between the global supply chain and the local manufacturing execution process.
The integrated MES template provides a basis for MES expansion to support operations for two new innovative manufacturing plants currently under construction at the Takeda Ireland Grange Castle campus. The new plants are solid oral dose and liquid vial based drug products employing high containment and cell culture technologies respectively.
Related News
-
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Loading Potential – Artificial Intelligence for Pharma Manufacturing
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News On track at CPHI Barcelona - The Track Sponsor interview: Procaps
In our packed out content sessions at CPHI Barcelona this year we focus on some of the hottest topics coming up in the pharma industry, with each track sponsored by a leading expert in the field. -
News Your Prescription for Marketing Success: Digital Pharma Marketing Toolkit – Free eBook
Download your FREE pharma marketing eBook to learn why it is so important for pharmaceutical marketeers to develop their digital content marketing strategies in order to establish their companies as thought leaders and industry experts. -
News 3 ways ChatGPT will impact pharma marketing teams
What does the rise of AI-powered chatbots such as ChatGPT and GPT-4 mean for pharma marketeers? -
News Pharma needs ‘mindset change’ to unlock benefits of digitalisation – CPHI Frankfurt preview
For more information about digitalisation in pharma, register to attend CPHI Frankfurt 2022.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance